Guy Molenaers Selected Research

Cerebral Palsy (Spastic Diplegia)

3/2021	Proximal femoral derotation osteotomy in children with CP : long term outcome and the role of age at time of surgery.
1/2020	Randomized controlled trial combining constraint-induced movement therapy and action-observation training in unilateral cerebral palsy: clinical effects and influencing factors of treatment response.
1/2020	Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation.
1/2020	Tone Reduction and Physical Therapy: Strengthening Partners in Treatment of Children with Spastic Cerebral Palsy.
1/2019	Selective dorsal rhizotomy improves muscle forces during walking in children with spastic cerebral palsy.
1/2019	Medial gastrocnemius volume and echo-intensity after botulinum neurotoxin A interventions in children with spastic cerebral palsy.
1/2018	Combining constraint-induced movement therapy and action-observation training in children with unilateral cerebral palsy: a randomized controlled trial.
2/2017	The Effect of Additional Virtual Reality Training on Balance in Children with Cerebral Palsy after Lower Limb Surgery: A Feasibility Study.
1/2017	The Direct Anterior Approach for Complex Primary Total Hip Arthroplasty: The Extensile Acetabular Approach on a Regular Operating Room Table.
1/2016	Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral Palsy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy Molenaers Research Topics

Disease

27	Cerebral Palsy (Spastic Diplegia) 03/2021 - 01/2006
5	Muscle Spasticity (Spastic) 01/2020 - 03/2013
3	Hemiplegia (Spastic Hemiplegia) 01/2008 - 10/2006
2	Pain (Aches) 12/2019 - 11/2013
2	Movement Disorders (Movement Disorder) 01/2010 - 09/2006
1	Muscle Weakness 01/2020
1	Muscular Atrophy (Muscle Atrophy) 03/2013
1	Atrophy 03/2013
1	Malnutrition (Nutritional Deficiencies) 03/2008

Drug/Important Bio-Agent (IBA)

12	Type A Botulinum Toxins (Botox)FDA Link 01/2020 - 01/2006
5	Botulinum Toxins (Botulinum Toxin)IBA 01/2016 - 09/2006
3	incobotulinumtoxinA FDA Link 01/2020 - 03/2013
2	Carbon Fiber (Grafil)IBA 01/2008 - 10/2006
1	Pain-FreeIBA 12/2019
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2017
1	AntibodiesIBA 09/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2008

Therapy/Procedure

6	Injections 01/2020 - 01/2007
5	Physical Therapy Modalities (Physical Therapy Technique) 01/2020 - 01/2006
4	Therapeutics 01/2020 - 05/2012
2	Osteotomy 03/2021 - 01/2017
2	Hip Replacement Arthroplasty (Total Hip Replacement) 12/2019 - 01/2017
2	Foot Orthoses 01/2008 - 10/2006
2	Orthotic Devices (Orthosis) 01/2008 - 10/2006
1	Resistance Training 01/2020
1	Rhizotomy 01/2019
1	Orthopedic Procedures 02/2017
1	Splints (Splint) 01/2008
1	Treatment Delay 01/2006
1	Operative Surgical Procedures 01/2006